suzetrigine - Search News

FDA Approves First Non-Opioid Painkiller In 20+ Years

FDA Approves New Non-Opioid Painkiller Journavx for Acute Pain | Watch

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by Vertex Pharmaceuticals,

The American Journal of Manage… · 3d

Suzetrigine: First-in-Class Nonopioid Pain Therapy Is Approved by FDA

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as a selective NaV1.8 pain signal inhibitor, an alternative to opiates.

FOX News on MSN · 1d

FDA approves opioid-free pain medication with 'no sign of addiction'

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.

13h

Vertex Pharmaceuticals: Strong Buy Rating Driven by Suzetrigine Approval and Promising Market Prospects

Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating on January 31.Maximize Your ...

Hosted on MSN20h

Brand-new painkiller approved by US health agency

Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 ...

Pharmabiz2d

Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain

Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Approves First Non-Opioid Painkiller In 20+ Years

Trending now

Related topics